SCHEMBL9572816

SCHEMBL9572816

CCCCCC(=O)c1[nH]c2ccccc2c1NCc1ccc(OC)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 2/20 0.54
▸ APP P05067 1/20 0.52
▸ MAPT P10636 2/20 0.48
▸ KMT2A Q03164 3/20 0.47
▸ LMNA P02545 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ GABRP O00591 1/20 0.46
▸ GABRD O14764 1/20 0.46
▸ GABRA1 P14867 1/20 0.46
▸ GABRB1 P18505 1/20 0.46
▸ GABRG2 P18507 1/20 0.46
▸ GABRB3 P28472 1/20 0.46
▸ GABRA5 P31644 1/20 0.46
▸ GABRA3 P34903 1/20 0.46
▸ GABRA2 P47869 1/20 0.46
▸ GABRB2 P47870 1/20 0.46
▸ GABRA4 P48169 1/20 0.46
▸ GABRE P78334 1/20 0.46
▸ GABRA6 Q16445 1/20 0.46
▸ GABRG1 Q8N1C3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9573321 0.84 EPHX2 (0.50) EPHX2MAPTKMT2ALMNASMN1; SMN2
SCHEMBL9572914 0.76 KDM4E (0.50) MAPTKMT2ALMNASMN1; SMN2GABRA1
SCHEMBL9572939 0.75 ALOX15 (0.45) MAPTLMNAKDM4EGAAHPGD
SCHEMBL17335626 0.72 EPHX2 (0.97) EPHX2MAPTKMT2AMEN1HPGD
SCHEMBL28664721 0.71 EPHX2 (1.00) EPHX2MAPTKMT2AMEN1HPGD
SCHEMBL28721305 0.71 EPHX2 (1.00) EPHX2MAPTKMT2AMEN1HPGD
SCHEMBL28721241 0.71 EPHX2 (1.00) EPHX2MAPTKMT2AMEN1HPGD
SCHEMBL29549399 0.71 EPHX2 (1.00) EPHX2MAPTKMT2AMEN1HPGD
SCHEMBL17778311 0.71 EPHX2 (1.00) EPHX2MAPTKMT2AMEN1HPGD
SCHEMBL15417418 0.69 EPHX2 (0.83) EPHX2HPGDALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562832-A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use SANKYO COMPANY LIMITED (JP) 1993-09-29 — — EP disclosed
Send feedback